|
LivostinDrug - Livostin The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION/DROPS; OPHTHALMIC
Active Ingredient(s) -
Levocabastine Hydrochloride
Strength -
EQ 0.05% BASE
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
020219
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 10, 1993
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Novartis Pharmaceuticals Corp
Livostin
Levobunolol Hcl 0.25% Solution/drops; Ophthalmic
Levobunolol Hcl 0.5% Solution/drops; Ophthalmic Levobunolol Hcl 0.25% Solution/drops; Ophthalmic Levobunolol Hcl 0.5% Solution/drops; Ophthalmic Chirocaine Eq 2.5mg Base/ml Injectable; Injection Chirocaine Eq 5mg Base/ml Injectable; Injection Chirocaine Eq 7.5mg Base/ml Injectable; Injection Livostin Eq 0.05% Base Suspension/drops; Ophthalmic Levobunolol Hcl 0.25% Solution/drops; Ophthalmic Levobunolol Hcl 0.5% Solution/drops; Ophthalmic NewDrugInformation |